An interventional study of Bariatric surgery strategy in Heart Failure With Preserved Ejection Fraction and Atrial Fibrillation, sponsored by University Medical Center Groningen. Terminated at 2 sites in Netherlands. Open to participants aged 45 Years to 70 Years. Per ClinicalTrials.gov, last updated 2026-11-12.
Sponsored by University Medical Center Groningen · Not applicable, Interventional, and Treatment
slow patient inclusion
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 16 studies in Atrial Fibrillation by University Medical Center Groningen — 3 open to participants now, 3 under way, none of them phase 3. Atrial Fibrillation · University Medical Center Groningen.
Among the 16 studies in Atrial Fibrillation by University Medical Center Groningen, this one is the 12th largest by enrollment of the 13 interventional ones that give a count, is one of 4 that started in 2024, is one of 9 with no phase, and was the 12th registered.
4,018 studies on the registry are indexed under Atrial Fibrillation; 965 are open to participants now.
Browse Atrial Fibrillation studies →3 of the 16 studies in Atrial Fibrillation by University Medical Center Groningen are open now, in 4 countries. Recruiting first, the newest first:
University Medical Center Groningen · Sites in Netherlands
Ages 18–80
University Medical Center Groningen · Sites in Netherlands
Ages 65–80
University Medical Center Groningen · Sites in France, Germany, Italy and 1 more country
Ages 18+
By country, each count listing its studies:
Of the 613 Atrial Fibrillation studies recruiting now, 410 (67%) set no upper age limit and 44 (7%) stop at 75 or younger; 21 take children under 18; 43 take healthy volunteers.
This study: 45 Years to 70 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
16 studies; the count open now beside each. This study's row is marked.
First in 2000; this study’s year is marked. 4 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 1 is below the median of 150 across 2,480 interventional studies indexed under Atrial Fibrillation.
Median enrollment 220 across the 13 interventional studies, 503 across the 3 observational. Of the 12 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
University Medical Center Groningen is the lead sponsor of 627 studies on the registry; 175 are open to participants now.
None of the studies under way reaches primary completion within a year.
Among the 16 studies in Atrial Fibrillation by University Medical Center Groningen, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this clinical trial is to evaluate if a bariatric surgery strategy will improve clinical endpoints, cardiac parameters and functional status in patients with obesity (with BMI 32-40 kg/m2) and symptomatic HF with preserved or mildly reduced LVEF in combination with AF, as compared to standard of care. Patients will be randomized to either the Intervention group receiving bariatric surgery including an intensive pre- and postoperative treatment scheme or to the control group receiving standard of care.
The primary objective is to study the effect of a bariatric surgery strategy on the hierarchical occurrence of: 1) all-cause mortality within 2 years, 2) emergency room visit or hospitalization for HF within 2 years, 3) recurrent ECG-documented AF within 2 years, 4) decrease of ≥30gr of left ventricular (LV) mass on transthoracic echocardiography, and 5) improvement of ≥5 points on the Kansas City Cardiomyopathy Questionnaire (KCCQ).
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
LVEF (left ventricular ejection fraction)
The share of blood the heart’s main pumping chamber (the left ventricle) pushes out with each beat, measured by an echocardiogram (heart ultrasound) or a MUGA scan. About 50–70% is normal.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
BMI (body mass index)
Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.
What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The intervention group will receive bariatric surgery including an intensive pre- and postoperative treatment scheme
Procedure: Bariatric surgery strategy
The control group will receive standard of care
Bariatric surgery including an intensive pre- and postoperative treatment scheme
Hierarchical endpoint
The hierarchical occurrence of: 1) All-cause mortality; 2) Emergency room visit or hospitalization for HF; 3) Recurrent ECG-documented AF; 4) Decrease of ≥30gr of LV mass on transthoracic echocardiography; 5) Improvement of ≥5 points on the Kansas City Cardiomyopathy Questionnaire (Scores are transformed to a range of 0-100, in which higher scores reflect better health status)
Time frame: 2 years
All-cause mortality
All-cause mortality
Time frame: 2 years
Emergency room visit or hospitalization for HF
Emergency room visit or hospitalization for HF
Time frame: 2 years
Rate of recurrent AF
Recurrent AF documented on ECG
Time frame: 2 years
Decrease of left ventricular mass
Decrease of ≥30gr of LV mass measured by transthoracic echocardiography
Time frame: 2 years
Kansas City Cardiomyopathy Questionnaire improvement
Improvement of ≥5 points on the Kansas City Cardiomyopathy Questionnaire (scores are transformed to a range of 0-100, in which higher scores reflect better health status)
Time frame: 2 years
Weight reduction
Measuring weight during clinical trial
Time frame: 2 years
Medication changes after surgery
Medication changes after surgery
Time frame: 2 years
Concomitant cardiovascular conditions and relevant comorbidities
Medical history of patient
Time frame: 2 years
Change in left atrial volume
Change in left atrial volume measured by transthoracic echocardiography
Time frame: 2 years
Change in left ventricular diastolic dysfunction
Change in left ventricular diastolic dysfunction measured by transthoracic echocardiography with the definition according to the leading guidelines
Time frame: 2 years
Change in left ventricular ejection fraction
Change in left ventricular ejection fraction measured by transthoracic echocardiography
Time frame: 2 years
Change in right ventricular function
Change in right ventricular function measured by transthoracic echocardiography with the definition according to the leading guidelines
Time frame: 2 years
Change in diameter of epicardial fat
Change in diameter of epicardial fat measured by transthoracic echocardiography
Time frame: 2 years
Healthcare resource use/costs
Measured with the iMedical Consumption Questionnaire (instrument for measuring medical consumption, costs will be estimated by given answers and relation to known costs of the items of medical consumption)
Time frame: 2 years
Health related quality of life / utility
Measured with the 5-level EQ-5D questionnaire (The descriptive system comprises five dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression)
Time frame: 2 years
Plan to share: No
No publications or documents are linked to this record.
Ran from Jul 2024 to primary completion in Aug 2026, 25 months.
Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 12, 2026: primary completion Oct 2027 → Aug 2026 and completion Oct 2027 → Aug 2026.
Earlier changes are on the record history on ClinicalTrials.gov ↗
How these figures are worked out, and which studies are left out of them.
slow patient inclusion
slow patient inclusion
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is terminated, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University Medical Center Groningen →